Sumitomo Dainippon Pharma Co. Ltd.

09/10/2021 | Press release | Distributed by Public on 09/09/2021 19:13

Myovant Sciences and Pfizer Announce FDA Acceptance of Supplemental New Drug Application for MYFEMBREE for the Management of Moderate to Severe Pain Associated With Endometriosis